Who owns Checkpoint Therapeutics Inc Com New?
- Ticker: CKPT
- CUSIP Number: 162828206
Tip: Access positions for across all investors
Analyze quarterly positions in Checkpoint Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv Download as ExcelTop investors of Checkpoint Therapeutics stock
Who bought or sold Checkpoint Therapeutics Inc Com New this quarter?
Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
---|---|---|---|---|---|
Armistice Capital | 2.1M | $3.5M | 46% | Sep 2023 |
|
Vanguard Group | 548k | $1.3M | 14% | Dec 2023 |
|
Sabby Management | 205k | $349k | 100% | Sep 2023 |
|
Geode Capital Management | 173k | $294k | 34% | Sep 2023 |
|
National Asset Management | 163k | $374k | 232% | Dec 2023 |
|
Advisor Group Holdings | 163k | $374k | 52% | Dec 2023 |
|
D. E. Shaw & Co | 141k | $322k | 100% | Dec 2023 |
|
Pvg Asset Management | 115k | $264k | 4% | Dec 2023 |
|
BlackRock | 104k | $176k | -11% | Sep 2023 |
|
Citadel Advisors | 87k | $198k | 228% | Dec 2023 |
|
Legacy Wealth Asset Management | 85k | $195k | 0% | Dec 2023 |
|
Wealth Enhancement Advisory Services | 85k | $195k | 78% | Dec 2023 |
|
Susquehanna International | 75k | $128k | -2% | Sep 2023 |
|
Royal Bank of Canada | 61k | $162k | -1% | Dec 2023 |
|
Park Avenue Securities | 60k | $137k | 0% | Dec 2023 |
|
Envestnet Asset Management | 48k | $82k | 7% | Sep 2023 |
|
Jane Street | 41k | $93k | 100% | Dec 2023 |
|
State Street Corporation | 36k | $61k | 32% | Sep 2023 |
|
Goss Wealth Management | 30k | $51k | 20% | Sep 2023 |
|
Northern Trust | 27k | $45k | 77% | Sep 2023 |
|
XTX Topco | 21k | $36k | 100% | Sep 2023 |
|
Rsm Us Wealth Management | 19k | $44k | 100% | Dec 2023 |
|
Cetera Investment Advisers | 18k | $30k | 16% | Sep 2023 |
|
Wells Fargo & Company | 17k | $39k | 6% | Dec 2023 |
|
Emfo | 16k | $36k | 0% | Dec 2023 |
|
Two Sigma Securities | 14k | $32k | 100% | Dec 2023 |
|
Simplex Trading | 14k | $31k | 532% | Dec 2023 |
|
Hrt Financial | 13k | $30k | 100% | Dec 2023 |
|
Millennium Management | 12k | $27k | -44% | Dec 2023 |
|
Squarepoint Ops | 12k | $27k | 100% | Dec 2023 |
|
Ironwood Investment Management | 12k | $27k | -9% | Dec 2023 |
|
CIBC Global Asset Management | 11k | $19k | 0% | Sep 2023 |
|
Gladstone Institutional Advisory | 10k | $23k | 100% | Dec 2023 |
|
Ark & Tlk Investments | 10k | $23k | 100% | Dec 2023 |
|
Morgan Stanley | 6.9k | $12k | 14% | Sep 2023 |
|
Tower Research Capital | 5.8k | $9.9k | 100% | Sep 2023 |
|
Bartlett & Co. | 4.0k | $9.0k | -20% | Dec 2023 |
|
Bartlett & Co. Wealth Management | 4.0k | $9.0k | -20% | Dec 2023 |
|
UBS Group | 1.5k | $3.5k | -5% | Dec 2023 |
|
Householder Group Estate & Retirement Specialist | 300.00 | $0 | 0% | Dec 2023 |
|
TSFG | 300.00 | $999.990000 | 0% | Dec 2023 |
|
Bank of America Corporation | 25.00 | $57.692500 | 2400% | Dec 2023 |
|
FMR | 5.00 | $9.000000 | -100% | Sep 2023 |
|
Jpmorgan Chase & Co | 1.00 | $2.000000 | -97% | Dec 2023 |
|
Who sold out of Checkpoint Therapeutics?
Fund or Company Name | Date Sold | Shares Held | Valued At |
---|---|---|---|
Apollon Wealth Management | Sep 2023 | 14k | $24k |
Ethos Financial Group | Sep 2023 | 12k | $21k |
D.A. Davidson & Co. | Sep 2023 | 10k | $17k |
Group One Trading | Jun 2023 | 3.7k | $9.2k |